Report Detail

Pharmaceuticals & Healthcare OBI Pharma Inc (4174) - Financial and Strategic SWOT Analysis Review

  • RnM1038206
  • |
  • 14 June, 2019
  • |
  • Global
  • |
  • 25 pages
  • |
  • GlobalData
  • |
  • Pharmaceuticals & Healthcare

OBI Pharma Inc (4174) - Financial and Strategic SWOT Analysis Review

Table of Contents

    Section 1 - About the Company

      OBI Pharma Inc - Key Information

        OBI Pharma Inc - Overview

          OBI Pharma Inc - Key Employees

            OBI Pharma Inc - Key Employee Biographies

              OBI Pharma Inc - Key Operational Heads

                OBI Pharma Inc - Major Products and Services

                  OBI Pharma Inc - History

                    OBI Pharma Inc - Company Statement

                      OBI Pharma Inc - Locations And Subsidiaries

                        OBI Pharma Inc - Key Manufacturing facilities

                          Head Office

                            Other Locations & Subsidiaries

                              Section 2 - Company Analysis

                                OBI Pharma Inc - Business Description

                                  OBI Pharma Inc - Corporate Strategy

                                    OBI Pharma Inc - SWOT Analysis

                                      SWOT Analysis - Overview

                                        OBI Pharma Inc - Strengths

                                          OBI Pharma Inc - Weaknesses

                                            OBI Pharma Inc - Opportunities

                                              OBI Pharma Inc - Threats

                                                OBI Pharma Inc - Key Competitors

                                                  Section 3 - Company Financial Performance Charts

                                                    OBI Pharma Inc - Financial Ratios

                                                      Financial Ratios - Capital Market Ratios

                                                        Financial Ratios - Annual Ratios

                                                          Financial Ratios - Interim Ratios

                                                            Financial Ratios - Ratio Charts

                                                              Section 4 - Appendix

                                                                Appendix

                                                                  Methodology

                                                                    Ratio Definitions

                                                                      About GlobalData

                                                                        Contact Us

                                                                          Disclaimer

                                                                            Note*: Some sections may be missing if data is unavailable for the company

                                                                            Summary

                                                                            OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a cancer vaccine for epithelial cancers other than breast and ovarian cancer. It also develops active immunotherapies intended for the treatment of various lung, prostate, pancreatic, stomach and ovarian cancers. OBI Pharma develops its pipeline products through its carbohydrate synthesis discovery platform. The company has collaboration with research institutes including cancer centers to enhance its pipeline products. It operates in the US, Taiwan and China. OBI Pharma is headquartered in Taipei, Taiwan.

                                                                            OBI Pharma Inc Key Recent Developments

                                                                            Feb 14,2019: New Scientific Research Provides Link Between Globo-series Glycosphingolipid (GSL) Antigens and Tumor Survival in Breast Cancer

                                                                            This comprehensive SWOT profile of OBI Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

                                                                            This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OBI Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

                                                                            The profile contains critical company information including*,

                                                                            - Business description – A detailed description of the company’s operations and business divisions.
                                                                            - Corporate strategy – Analyst’s summarization of the company’s business strategy.
                                                                            - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
                                                                            - Company history – Progression of key events associated with the company.
                                                                            - Major products and services – A list of major products, services and brands of the company.
                                                                            - Key competitors – A list of key competitors to the company.
                                                                            - Key employees – A list of the key executives of the company.
                                                                            - Executive biographies – A brief summary of the executives’ employment history.
                                                                            - Key operational heads – A list of personnel heading key departments/functions.
                                                                            - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
                                                                            - Key manufacturing facilities – A list of key manufacturing facilities of the company.
                                                                            - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
                                                                            - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

                                                                            Note*: Some sections may be missing if data is unavailable for the company.

                                                                            Key benefits of buying this profile include,

                                                                            You get detailed information about the company and its operations to identify potential customers and suppliers.
                                                                            - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

                                                                            Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
                                                                            - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

                                                                            Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
                                                                            - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

                                                                            Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
                                                                            - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

                                                                            Gain key insights into the company for academic or business research.
                                                                            - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



                                                                            REPORT YOU MIGHT BE INTERESTED

                                                                            Purchase this Report

                                                                            $300.00
                                                                            $600.00
                                                                            $900.00
                                                                            235.77
                                                                            471.55
                                                                            707.32
                                                                            263.52
                                                                            527.05
                                                                            790.57
                                                                            32,151.00
                                                                            64,302.00
                                                                            96,453.00
                                                                            20,806.44
                                                                            41,612.88
                                                                            62,419.32
                                                                            Credit card Logo

                                                                            Related Reports


                                                                            Reason to Buy

                                                                            Request for Sample of this report